American Bio Medica (ABMC) 10-Q 16 Nov 15 2015 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Nov. 13, 2015
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q3
Entity Registrant Name	AMERICAN BIO MEDICA CORP
Entity Central Index Key	896,747
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	ABMC
Entity Common Stock, Shares Outstanding		26,032,930

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Current assets
Cash and cash equivalents	$ 224,000	$ 352,000
Accounts receivable, net of allowance for doubtful accounts of $46,000 at September 30, 2015, and $47,000 at December 31, 2014	802,000	814,000
Inventory, net of allowance of $387,000 at September 30, 2015 and $324,000 at December 31, 2014	1,848,000	1,722,000
Current portion of deferred financing	0	43,000
Prepaid expenses and other current assets	80,000	85,000
Total current assets	2,954,000	3,016,000
Property, plant and equipment, net	923,000	983,000
Patents	69,000	65,000
Other assets	14,000	14,000
Deferred finance costs	256,000	0
Total assets	4,216,000	4,078,000
Current liabilities
Accounts payable	429,000	410,000
Accrued expenses and other current liabilities	211,000	192,000
Wages payable	287,000	264,000
Line of credit, net	931,000	979,000
Current portion of long-term debt, net	75,000	858,000
Total current liabilities	1,933,000	2,703,000
Other liabilities	68,000	68,000
Related party note	124,000	124,000
Long-term debt	934,000	213,000
Total liabilities	$ 3,059,000	$ 3,108,000
COMMITMENTS AND CONTINGENCIES
Stockholders' equity:
Preferred stock; par value $.01 per share; 5,000,000 shares authorized, 0 issued and outstanding at September 30, 2015 and December 31, 2014
Common stock; par value $.01 per share; 50,000,000 shares authorized; 26,032,930 issued and outstanding at September 30, 2015 and 23,648,315 issued and outstanding at December 31, 2014	$ 260,000	$ 236,000
Additional paid-in capital	20,649,000	20,356,000
Accumulated deficit	(19,752,000)	(19,622,000)
Total stockholders’ equity	1,157,000	970,000
Total liabilities and stockholders’ equity	$ 4,216,000	$ 4,078,000

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Allowance For Doubtful Accounts Receivable, Current (in dollars)	$ 46,000	$ 47,000
Inventory Valuation Reserves	$ 387,000	$ 324,000
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	26,032,930	23,648,315
Common stock, shares outstanding	26,032,930	23,648,315

Condensed Statements of Operati

Condensed Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Net sales	$ 1,590,000	$ 1,750,000	$ 4,860,000	$ 5,604,000
Cost of goods sold	823,000	1,027,000	2,543,000	3,213,000
Gross profit	767,000	723,000	2,317,000	2,391,000
Operating expenses:
Research and development	45,000	92,000	125,000	183,000
Selling and marketing	291,000	280,000	899,000	839,000
General and administrative	388,000	475,000	1,332,000	1,408,000
Operating Expenses, Total	724,000	847,000	2,356,000	2,430,000
Operating income / (loss)	43,000	(124,000)	(39,000)	(39,000)
Other income / (expense):
Other income, net	0	15,000	72,000	16,000
Interest income	0	(1,000)	(1,000)	0
Interest expense	(45,000)	(60,000)	(162,000)	(187,000)
Loss on disposition of assets, net	0	(41,000)	0	(41,000)
Other Expenses, Total	(45,000)	(87,000)	(91,000)	(212,000)
Loss before tax	(2,000)	(211,000)	(130,000)	(251,000)
Income tax benefit / (expense)	0	0	0	(1,000)
Net loss	$ (2,000)	$ (211,000)	$ (130,000)	$ (252,000)
Basic and diluted loss per common share (in dollars per share)	$ 0	$ (0.01)	$ (0.01)	$ (0.01)
Weighted average number of shares outstanding - basic and diluted (in shares)	26,032,930	23,466,785	25,557,021	23,268,792

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net loss	$ (130,000)	$ (252,000)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	70,000	85,000
Loss on disposal of fixed assets	0	41,000
Amortization of debt issuance costs	187,000	216,000
Provision for bad debts	(1,000)	(12,000)
Provision for slow moving and obsolete inventory	63,000	30,000
Share-based payment expense	27,000	30,000
Changes in:
Accounts receivable	13,000	105,000
Inventory	(189,000)	189,000
Prepaid expenses and other current assets	5,000	3,000
Accounts payable	19,000	(87,000)
Accrued expenses and other current liabilities	18,000	(191,000)
Wages payable	23,000	47,000
Net cash provided by operating activities	105,000	204,000
Cash flows from investing activities:
Proceeds from sale of equipment	0	10,000
Purchase of property, plant and equipment	(10,000)	(21,000)
Patent application costs	(4,000)	(11,000)
Net cash used in investing activities	(14,000)	(22,000)
Cash flows from financing activities:
Proceeds from / (Payments on) debt financing	130,000	(183,000)
Deferred finance costs	(205,000)	(7,000)
Proceeds from lines of credit	5,090,000	5,082,000
Payments on lines of credit	(5,234,000)	(5,287,000)
Net cash used in financing activities	(219,000)	(395,000)
Net decrease in cash and cash equivalents	(128,000)	(213,000)
Cash and cash equivalents - beginning of period	352,000	646,000
Cash and cash equivalents - end of period	224,000	433,000
Supplemental disclosures of cash flow information
Cash paid during period for interest	$ 176,000	$ 186,000

Basis of Reporting

Basis of Reporting	9 Months Ended
	Sep. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Accounting [Text Block]	Note A - Basis of Reporting The accompanying unaudited interim condensed financial statements of American Bio Medica Corporation (the “Company”) have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Regulation S-X. Accordingly, these unaudited interim condensed financial statements do not include all information and footnotes required by U.S. GAAP for complete financial statement presentation. These unaudited interim condensed financial statements should be read in conjunction with the Company’s audited condensed financial statements and related notes contained in its Annual Report on Form 10-K for the year ended December 31, 2014. In the opinion of management, the interim condensed financial statements include all normal, recurring adjustments which are considered necessary for a fair presentation of the financial position of the Company at September 30, 2015, the results of our operations for the three and nine month periods ended September 30, 2015 and September 30, 2014, and cash flows for the nine month periods ended September 30, 2015 and September 30, 2014. Operating results for the three and nine months ended September 30, 2015 are not necessarily indicative of results that may be expected for the year ending December 31, 2015. Amounts at December 31, 2014 are derived from the Company’s audited financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2014. During the nine months ended September 30, 2015, there were no significant changes to the Company’s critical accounting policies, which are included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014. The preparation of these interim condensed financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, the Company evaluates estimates, including those related to product returns, bad debts, inventories, income taxes, warranty obligations, contingencies and litigation. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. These unaudited interim financial statements have been prepared assuming that the Company will continue as a going concern and, accordingly, do not include any adjustments that might result from the outcome of this uncertainty. The Company’s independent registered public accounting firm’s report on the financial statements included in its Annual Report on Form 10-K for the year ended December 31, 2014, contained an explanatory paragraph regarding the Company’s ability to continue as a going concern. As of the date of this report, the Company’s current cash balances, together with cash generated from future operations and amounts available under current credit facilities may not be sufficient to fund operations for the next 12 months if sales levels do not improve. If cash generated from operations is not sufficient to satisfy our working capital and capital expenditure requirements, the Company will be required to sell additional equity or obtain additional credit facilities. There is no assurance that such financing will be available or that the Company will be able to complete financing on satisfactory terms, if at all . Certain reclassifications have been made to the prior period to confirm to the presentation of the current period. In August 2015, FASB issued Accounting Standards Update (“ASU”) No 2015-14, “Revenue from Contracts with Customers”. This update defers the effective dates of ASU No. 2014-09 (originally issued in June 2014) for public business entities by one year, or until annual reporting periods beginning after December 15, 2017, including interim reporting periods within the reporting period. ASU No. 2014-09 gives entities a single comprehensive model to use in reporting information about the amount and timing of revenue resulting from contracts to provide goods or services to customers. The proposed ASU, which would apply to any entity that enters into contracts to provide goods or services, would supersede the revenue recognition requirements in Topic 605, Revenue Recognition, and most industry-specific guidance throughout the Industry Topics of the Codification. Additionally, the update would supersede some cost guidance included in Subtopic 605-35, Revenue Recognition – Construction-Type and Production-Type Contracts. The update removes inconsistencies and weaknesses in revenue requirements and provides a more robust framework for addressing revenue issues and more useful information to users of financial statements through improved disclosure requirements. In addition, the update improves comparability of revenue recognition practices across entities, industries, jurisdictions, and capital markets and simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. The Company is continuing to review the provisions of this ASU to determine if there will be any impact on its results of operations, cash flows or financial condition. Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.

Inventory

Inventory	9 Months Ended
	Sep. 30, 2015
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	Note B – Inventory September 30, 2015 December 31, 2014 Raw Materials $ 1,122,000 $ 1,136,000 Work In Process 449,000 390,000 Finished Goods 664,000 520,000 Allowance for slow moving and obsolete inventory (387,000) (324,000) $ 1,848,000 $ 1,722,000

Net Loss Per Common Share

Net Loss Per Common Share	9 Months Ended
	Sep. 30, 2015
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	Note C – Net Loss Per Common Share Basic net loss per common share is calculated by dividing the net loss by the weighted average number of outstanding common shares during the period. September 30, 2015 September 30, 2014 Warrants 2,385,000 3,303,000 Options 1,435,000 2,558,000 The number of securities not included in the diluted net loss per common share for the three and nine months ended September 30, 2015 and the three and nine months ended September 30, 2014 (because the effect would have been anti-dilutive) was 3,820,000 5,861,000

Litigation

Litigation	9 Months Ended
	Sep. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Legal Matters and Contingencies [Text Block]	Note D – Litigation From time to time, the Company is named in legal proceedings in connection with matters that arise during the normal course of business. While the ultimate result of any such litigation cannot be predicted, if the Company is unsuccessful in defending any such litigation, the resulting financial losses could have an adverse effect on the financial position, results of operations and cash flows of the Company. The Company is not aware of any significant litigation loss contingencies for which management believes it is both probable that a liability has been incurred and that the amount of the loss can be reasonably estimated.

Line of Credit and Debt

Line of Credit and Debt	9 Months Ended
	Sep. 30, 2015
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	Note E – Line of Credit and Debt September 30, 2015 December 31, 2014 Loan and Security Agreement with Cherokee Financial, LLC (1) $ 1,200,000 $ 0 Crestmark Line of Credit (2 931,000 0 First Niagara (3) (1) 0 348,000 Debenture financing (4) (2) 0 523,000 Bridge Loan with Cantone Asset Management, LLC (4) (3) 0 200,000 Imperium Line of Credit (5) 0 1,076,000 2,131,000 2,147,000 Less debt discount (Cherokee Financial, LLC Loan) (191,000) (97,000) Total debt $ 1,940,000 $ 2,050,000 Current portion $ 1,006,000 $ 1,837,000 Long-term portion $ 934,000 $ 213,000 (1) On March 26, 2015, the Company entered into a Loan and Security Agreement with Cherokee Financial, LLC (the “Cherokee LSA”). The purpose of the Cherokee LSA was to refinance the Series A Debentures and Cantone Asset Management LLC Bridge Loan (both of which matured on February 1, 2015) and the Mortgage Consolidation Loan with First Niagara Bank at a better interest rate. (2) On June 29, 2015, the Company entered into a Loan and Security Agreement with Crestmark Bank. The purpose of the Crestmark LSA was to refinance the Company’s line of credit with Imperium at a better interest rate. (3) The mortgage through First Niagara Bank was satisfied in full on March 27, 2015 via a refinancing with Cherokee Financial, LLC. (4) The Series A Debentures and Bridge Loan with Cantone Asset Management, LLC were both satisfied in full on March 27, 2015 via a refinancing with Cherokee Financial, LLC. (5) On June 29, 2015, the Imperium Line of Credit was satisfied in Full via a refinancing with Crestmark Bank. LOAN AND SECURITY AGREEMENT WITH CHEROKEE FINANCIAL, LLC. On March 26, 2015, the Company entered into a Loan and Security Agreement with Cherokee Financial, LLC (the “Cherokee LSA”). The purpose of the Cherokee LSA was to refinance the Company’s Series A Debentures and Cantone Asset Management Bridge Loan (both of which matured on February 1, 2015), as well as the Company’s Mortgage Consolidation Loan with First Niagara Bank at a better interest rate. The loan is collateralized by a first security interest in the same assets as the First Niagara Bank loan (i.e. real estate and machinery and equipment). Under the Cherokee LSA, the Company was provided the sum of $ 1,200,000 5 8 75,000 March 26, 2020 1 1 The Company issued 1.8 0.5 600,000 200,000 196,000 The Company received net proceeds of $ 80,000 1,015,000 60,000 19,000 19,000 3,000 4,000 8 511,000 5 15,000 15 689,000 The nine months ended September 30, 2015 includes $ 39,000 0 17,000 0 The Company recognized $ 48,000 0 24,000 0 13,000 As of September 30, 2015, the balance on the Cherokee LSA was $ 1,200,000 LINE OF CREDIT WITH CRESTMARK BANK (“CRESTMARK”) On June 29, 2015 (the “Closing Date”), the Company entered into a three-year Loan and Security Agreement (“LSA”) with Crestmark Bank (“Crestmark”), a new Senior Lender, to refinance the Company’s Line of Credit with Imperium Commercial Finance, LLC (“Imperium”). The Crestmark Line of Credit is used for working capital and general corporate purposes. Under the LSA, Crestmark is providing the Company with a Line of Credit of up to $ 1,500,000 500,000 The Maximum Amount is subject to an Advance Formula comprised of: 1) 90% of Eligible Accounts Receivables (excluding, receivables remaining unpaid for more than 90 days from the date of invoice and sales made to entities outside of the United States), and 2) up to 40% of eligible inventory plus up to 10% of Eligible Generic Packaging Components not to exceed the lesser of $500,000 (“Inventory Sub-Cap Limit”), or 100% of the Eligible Accounts Receivable 10,000 350,000 So long as any obligations are due to Crestmark, the Company must comply with a minimum Tangible Net Worth (“TNW”) Covenant. Under the LSA, as of June 30, 2015 and at all times thereafter, the Company must maintain a TNW of at least $ 1,650,000 50 In the event of a default of the LSA, which includes but is not limited to, failure of the Company to make any payment when due and non-compliance with the TNW covenant, permits Crestmark to charge an Extra Rate. The Extra Rate is the Company’s then current interest rate plus 12.75% per annum. Under the LSA, interest on the Crestmark Line of Credit is at a 5.25 9.35 12 In addition to the Loan Fee paid to Crestmark on the Closing Date, the Company had to pay a Success Fee (i.e. early termination fee) to Imperium in the amount of $ 50,000 75,000 12,000 3,000 6,000 8,000 0 The Company recognized $ 21,000 0 21,000 0 0 As of September 30, 2015, the balance on the Crestmark Line of Credit was $ 931,000 FIRST NIAGARA: MORTGAGE CONSOLIDATION LOAN On April 28, 2014, the Company entered into a Third Amendment to the Loan Agreement (the “Third Mortgage Consolidation Loan Amendment”) with First Niagara Bank. The Mortgage Consolidation Loan continued to be secured by the Company’s facility in Kinderhook, New York as well as various pieces of machinery and equipment. Under the Third Mortgage Consolidation Loan Amendment, the Mortgage Consolidation Loan was recast into a 3-year fully amortizing note through May 1, 2017. The interest rate of the amended facility was decreased from 9.25 8.25 14,115 13,199 1 4,200 Interest expense recognized was $ 5,000 24,000 0 8,000 0 348,000 DEBENTURE FINANCING/BRIDGE LOAN In August 2008, the Company completed an offering of Series A Debentures (“Series A Debentures”) and received gross proceeds of $ 750,000 8 August 1, 2012 645,000 15 634,500 15 150,000 200,000 15 300,000 87,000 76,000 0 65,000 44,000 0 21,000 3,000 0 0 On February 7, 2014, the Company paid $ 91,000 543,000 August 1, 2014 543,000 200,000 20,000 523,000 Throughout the course of the debenture financings, the Company utilized Cantone Research, Inc (“CRI”) as the placement agent and also used CRI’s assistance in obtaining forbearance agreements from debenture holders. CRI received placement agent fees, expense allowance fees and other fees for these services and these fees were recognized throughout 2008 and 2013. The last fee (in 2014; for assisting the Company in obtaining forbearance agreements from the holders) was 2 7,000 1 58,575 0.12 1,000 15,000 0 85,000 0 28,000 0 0 The Company recognized $ 22,000 85,000 0 28,000 0 0 LINE OF CREDIT WITH IMPERIUM COMMERCIAL FINANCE, LLC (“IMPERIUM”) On January 16, 2013 (the “Imperium Closing Date”), the Company entered into a 3-year Loan and Security Agreement (“LSA”) with Imperium, a Senior Lender. Under the LSA, the Company was provided with a revolving loan facility (the “Imperium Line of Credit”), which was secured by a first security interest in all receivables, inventory, and intellectual property rights along with a second security interest in machinery and equipment (together the “Collateral”). On March 6, 2014, Imperium amended the Borrowing Base of the Imperium Line of Credit. More specifically, the amount available under the Imperium Line of Credit was capped to the lower of (i) $1,000,000, or (ii) 100% of the eligible outstanding accounts receivable. The Imperium facility also originally included a supplemental advance that was a discretionary facility secured by the same Collateral as the Imperium Line of Credit. Under the LSA, so long as any obligations were due to Imperium, the Company was required to maintain certain minimum EBITDA (Earnings Before Interest, Taxes Depreciation and Amortization) requirements. The Company did not comply with this covenant starting in the First Quarter of 2013. The Company received a waiver from Imperium for the three months ended March 31, 2013 (for which the Company paid a fee of $10,000). No further formal waivers were issued, but no notice of default was received either. The Company incurred $ 435,000 3 50,000 The Company recognized $ 137,000 69,000 103,000 0 34,000 The Company incurred $ 39,000 76,000 0 25,000 0 0

Stock Options _ Warrant Grants

Stock Options / Warrant Grants	9 Months Ended
	Sep. 30, 2015
Stockholders Equity Note [Abstract]
Stockholders Equity Note Disclosure [Text Block]	Note F - Stock Options / Warrant Grants Stock Options The Company currently has three non-statutory stock option plans, the Fiscal 2000 Non-statutory Stock Option Plan (the “2000 Plan”), the Fiscal 2001 Non-statutory Stock Option Plan (the “2001 Plan”) and the 2013 Equity Compensation Plan (the “2013 Plan”). During the nine months ended September 30, 2015, the Company issued options (all under the 2001 Plan) to purchase 90,000 250,000 80,000 During the three months ended September 30, 2015, the Company issued 0 0 Nine months ended September 30, 2015 Nine months ended September 30, 2014 Aggregate Aggregate Intrinsic Weighted Intrinsic Weighted Value as of Average Value as of Average September Exercise September Exercise 30, Shares Price 30, 2015 Shares Price 2014 Options outstanding at beginning of period 1,295,000 $ 0.27 3,316,000 $ 0.69 Granted 340,000 $ 0.12 80,000 $ 0.12 Exercised 0 NA 0 NA Cancelled/expired (200,000) $ 0.90 (838,000) $ 1.07 Options outstanding at end of period 1,435,000 0.14 $ 16,300 2,558,000 $ 0.22 $ 6,150 Options exercisable at end of period 1,027,000 $ 0.15 2,209,000 $ 0.23 Nine months ended September 30, 2015 2014 Volatility 63% - 64% 197% Expected term (years) 10 7.5 yrs Risk-free interest rate 1.92% - 2.33% 0.87% Dividend yield 0% 0% As of September 30, 2015, there was approximately $ 40,000 5 32 Warrants Nine months ended September 30, 2015 Nine months ended September 30, 2014 Aggregate Aggregate Weighted Intrinsic Weighted Intrinsic Average Value as of Average Value as of Exercise September Exercise September Shares Price 30, 2015 Shares Price 30, 2014 Warrants outstanding at beginning of period 3,303,000 $ 0.17 3,303,000 $ 0.17 Granted 0 NA 0 NA Exercised 0 NA 0 NA Cancelled/expired (918,000) $ 0.15 0 $ 0.14 Warrants outstanding at end of period 2,385,000 $ 0.17 $ 0 3,303,000 $ 0.17 $ 0 Warrants exercisable at end of period 2,385,000 $ 0.17 3,303,000 $ 0.17 The Company recognized $ 100,000 50,000 0 25,000 The increase in costs from an annual comparison perspective is related to the accelerated amortization of the expense due to the early termination of the Imperium Line of Credit. As of September 30, 2015, there is $ 0

Basis of Reporting (Policies)

Basis of Reporting (Policies)	9 Months Ended
	Sep. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
New Accounting Pronouncements, Policy [Policy Text Block]	Certain reclassifications have been made to the prior period to confirm to the presentation of the current period. In August 2015, FASB issued Accounting Standards Update (“ASU”) No 2015-14, “Revenue from Contracts with Customers”. This update defers the effective dates of ASU No. 2014-09 (originally issued in June 2014) for public business entities by one year, or until annual reporting periods beginning after December 15, 2017, including interim reporting periods within the reporting period. ASU No. 2014-09 gives entities a single comprehensive model to use in reporting information about the amount and timing of revenue resulting from contracts to provide goods or services to customers. The proposed ASU, which would apply to any entity that enters into contracts to provide goods or services, would supersede the revenue recognition requirements in Topic 605, Revenue Recognition, and most industry-specific guidance throughout the Industry Topics of the Codification. Additionally, the update would supersede some cost guidance included in Subtopic 605-35, Revenue Recognition – Construction-Type and Production-Type Contracts. The update removes inconsistencies and weaknesses in revenue requirements and provides a more robust framework for addressing revenue issues and more useful information to users of financial statements through improved disclosure requirements. In addition, the update improves comparability of revenue recognition practices across entities, industries, jurisdictions, and capital markets and simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. The Company is continuing to review the provisions of this ASU to determine if there will be any impact on its results of operations, cash flows or financial condition. Management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.

Inventory (Tables)

Inventory (Tables)	9 Months Ended
	Sep. 30, 2015
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	Inventory is comprised of the following: September 30, 2015 December 31, 2014 Raw Materials $ 1,122,000 $ 1,136,000 Work In Process 449,000 390,000 Finished Goods 664,000 520,000 Allowance for slow moving and obsolete inventory (387,000) (324,000) $ 1,848,000 $ 1,722,000

Net Loss Per Common Share (Tabl

Net Loss Per Common Share (Tables)	9 Months Ended
	Sep. 30, 2015
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Diluted net loss per common share includes the weighted average dilutive effect of stock options and warrants. Potential common shares outstanding as of September 30, 2015 and 2014: September 30, 2015 September 30, 2014 Warrants 2,385,000 3,303,000 Options 1,435,000 2,558,000

Line of Credit and Debt (Tables

Line of Credit and Debt (Tables)	9 Months Ended
	Sep. 30, 2015
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments [Table Text Block]	The Company’s Line of Credit and Debt consisted of the following as of September 30, 2015 and December 31, 2014: September 30, 2015 December 31, 2014 Loan and Security Agreement with Cherokee Financial, LLC (1) $ 1,200,000 $ 0 Crestmark Line of Credit (2 931,000 0 First Niagara (3) (1) 0 348,000 Debenture financing (4) (2) 0 523,000 Bridge Loan with Cantone Asset Management, LLC (4) (3) 0 200,000 Imperium Line of Credit (5) 0 1,076,000 2,131,000 2,147,000 Less debt discount (Cherokee Financial, LLC Loan) (191,000) (97,000) Total debt $ 1,940,000 $ 2,050,000 Current portion $ 1,006,000 $ 1,837,000 Long-term portion $ 934,000 $ 213,000 (1) On March 26, 2015, the Company entered into a Loan and Security Agreement with Cherokee Financial, LLC (the “Cherokee LSA”). The purpose of the Cherokee LSA was to refinance the Series A Debentures and Cantone Asset Management LLC Bridge Loan (both of which matured on February 1, 2015) and the Mortgage Consolidation Loan with First Niagara Bank at a better interest rate. (2) On June 29, 2015, the Company entered into a Loan and Security Agreement with Crestmark Bank. The purpose of the Crestmark LSA was to refinance the Company’s line of credit with Imperium at a better interest rate. (3) The mortgage through First Niagara Bank was satisfied in full on March 27, 2015 via a refinancing with Cherokee Financial, LLC. (4) The Series A Debentures and Bridge Loan with Cantone Asset Management, LLC were both satisfied in full on March 27, 2015 via a refinancing with Cherokee Financial, LLC. (5) On June 29, 2015, the Imperium Line of Credit was satisfied in Full via a refinancing with Crestmark Bank.

Stock Options _ Warrant Grants

Stock Options / Warrant Grants (Tables)	9 Months Ended
	Sep. 30, 2015
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	The following table summarizes weighted-average assumptions using the Black-Scholes option-pricing model used on the date of the grants issued during the nine months ended September 30, 2014 and 2013: Nine months ended September 30, 2015 2014 Volatility 63% - 64% 197% Expected term (years) 10 7.5 yrs Risk-free interest rate 1.92% - 2.33% 0.87% Dividend yield 0% 0%
Warrant [Member]
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	Warrant activity for the nine months ended September 30, 2015 and the nine months ended September 30, 2014 is summarized as follows: Nine months ended September 30, 2015 Nine months ended September 30, 2014 Aggregate Aggregate Weighted Intrinsic Weighted Intrinsic Average Value as of Average Value as of Exercise September Exercise September Shares Price 30, 2015 Shares Price 30, 2014 Warrants outstanding at beginning of period 3,303,000 $ 0.17 3,303,000 $ 0.17 Granted 0 NA 0 NA Exercised 0 NA 0 NA Cancelled/expired (918,000) $ 0.15 0 $ 0.14 Warrants outstanding at end of period 2,385,000 $ 0.17 $ 0 3,303,000 $ 0.17 $ 0 Warrants exercisable at end of period 2,385,000 $ 0.17 3,303,000 $ 0.17
Employee Stock Option [Member]
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	Stock option activity for the nine months ended September 30, 2015, and the nine months ended September 30, 2014 is summarized as follows: Nine months ended September 30, 2015 Nine months ended September 30, 2014 Aggregate Aggregate Intrinsic Weighted Intrinsic Weighted Value as of Average Value as of Average September Exercise September Exercise 30, Shares Price 30, 2015 Shares Price 2014 Options outstanding at beginning of period 1,295,000 $ 0.27 3,316,000 $ 0.69 Granted 340,000 $ 0.12 80,000 $ 0.12 Exercised 0 NA 0 NA Cancelled/expired (200,000) $ 0.90 (838,000) $ 1.07 Options outstanding at end of period 1,435,000 0.14 $ 16,300 2,558,000 $ 0.22 $ 6,150 Options exercisable at end of period 1,027,000 $ 0.15 2,209,000 $ 0.23

Inventory (Details)

Inventory (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Inventory [Line Items]
Raw Materials	$ 1,122,000	$ 1,136,000
Work In Process	449,000	390,000
Finished Goods	664,000	520,000
Allowance for slow moving and obsolete inventory	(387,000)	(324,000)
Inventory, Net, Total	$ 1,848,000	$ 1,722,000

Net Loss Per Common Share (Deta

Net Loss Per Common Share (Details) - shares	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Warrant [Member]
Net Income Loss Per Common Share [Line Items]
Potential common shares outstanding	2,385,000	3,303,000
Stock Option [Member]
Net Income Loss Per Common Share [Line Items]
Potential common shares outstanding	1,435,000	2,558,000

Net Loss Per Common Share (De19

Net Loss Per Common Share (Details Textual) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	3,820,000	5,861,000	3,820,000	5,861,000

Line of Credit and Debt (Detail

Line of Credit and Debt (Details) - USD ($)		Sep. 30, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Long-term Debt, Gross		$ 2,131,000	$ 2,147,000
Less debt discount (Cherokee Financial, LLC Loan)		(191,000)	(97,000)
Total debt		1,940,000	2,050,000
Current portion		1,006,000	1,837,000
Long-term portion		934,000	213,000
Cherokee Financial LLC [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	[1]	1,200,000	0
Crestmark Line of Credit [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	[2]	931,000	0
Mortgage Payable To First Niagara [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	[3]	0	348,000
Series A Debentures [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	[4]	0	523,000
Bridge Loan with Cantone Asset Management, LLC [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	[4]	0	200,000
Imperium Line Of Credit [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	[5]	$ 0	$ 1,076,000
[1]	On March 26, 2015, the Company entered into a Loan and Security Agreement with Cherokee Financial, LLC (the “Cherokee LSA”). The purpose of the Cherokee LSA was to refinance the Series A Debentures and Cantone Asset Management LLC Bridge Loan (both of which matured on February 1, 2015) and the Mortgage Consolidation Loan with First Niagara Bank at a better interest rate.
[2]	On June 29, 2015, the Company entered into a Loan and Security Agreement with Crestmark Bank. The purpose of the Crestmark LSA was to refinance the Company’s line of credit with Imperium at a better interest rate.
[3]	The mortgage through First Niagara Bank was satisfied in full on March 27, 2015 via a refinancing with Cherokee Financial, LLC.
[4]	The Series A Debentures and Bridge Loan with Cantone Asset Management, LLC were both satisfied in full on March 27, 2015 via a refinancing with Cherokee Financial, LLC.
[5]	On June 29, 2015, the Imperium Line of Credit was satisfied in Full via a refinancing with Crestmark Bank.

Line of Credit and Debt (Deta21

Line of Credit and Debt (Details Textual) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Line of Credit Facility [Line Items]
Interest Expense, Debt	$ 5,000	$ 24,000
Long-term Debt, Total	1,940,000		$ 2,050,000
Mortgage Payable To First Niagara [Member]
Line of Credit Facility [Line Items]
Interest Expense, Debt	$ 13,199
Mortgage Consolidation Loan Initial Interest Percentage	8.25%
Debt Instrument, Maturity Date	May 1, 2017
Imperium Line Of Credit [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Collateral Fee	$ 2,500
Line of Credit Facility, Description	Success fee of $175,000 if Imperium terminates due to an event of default, or if we terminate and pre-pay all amounts due to Imperium prior to the stated expiration date of January 16, 2016.
Debt Instrument, Maturity Date	Jan. 16, 2016
Line of Credit Facility, Interest Rate Description	8% per annum plus “PIK” interest at a 2% per annum.
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage	2.00%
Series A Debentures [Member]
Line of Credit Facility [Line Items]
Long Term Debt Accrued Interest Rate	15.00%
Long-term Debt, Total	$ 523,000
Debt Instrument, Maturity Date	Feb. 1, 2015
Bridge Loan With Cantone Asset Management, LLC [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Interest Rate During Period	15.00%
Debt Instrument, Maturity Date	Feb. 1, 2015
Cherokee Financial LLC [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Maturity Date	May 15, 2015
Debt Instrument, Term	5 years
Line of Credit Facility, Interest Rate Description	annual interest rate of 8% plus a 1% annual oversight fee
Line of Credit Facility, Periodic Payment, Principal	$ 75,000
Crestmark Line of Credit [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Term	3 years
Line of Credit Facility, Interest Rate Description	WSJ Prime plus 2% with a floor or 5.25%; loan fee of 0.5% annually & monthly maintenance fee of 0.3% on actual loan balance from prior month. Early term fee of 3% if terminated in year 1 and 2% if terminated in year 2 or after (and prior to natural expiration).

Line of Credit and Debt - Loan

Line of Credit and Debt - Loan and Security Agreement With Cherokee Financial, LLC (Details Textual) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	Apr. 30, 2015	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Mar. 25, 2015
Line of Credit Facility [Line Items]
Debt Instrument, Face Amount		$ 0		$ 0
Interest Expense, Debt				5,000	$ 24,000
Interest Payable		$ 0		$ 0
Cherokee Financial LLC [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		8.00%		8.00%
Debt Instrument, Face Amount		$ 1,200,000		$ 1,200,000
Annual Fee Percentage				1.00%
Debt Instrument, Annual Principal Payment		75,000		$ 75,000
Debt Instrument, Term				5 years
Administrative Fees Percentage				1.00%
Cherokee Financial LLC [Member] | Final Balloon [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Maturity Date				Mar. 26, 2020
Cherokee Loan and Security Agreement [Member]
Line of Credit Facility [Line Items]
Debt Instrument Remaining Expenses Amortization Period				5 years
Placement Agent Fees				$ 60,000
Proceeds from Debt, Net of Issuance Costs				80,000
Repayments of Debt				1,015,000
Legal Fees				19,000
Debt Issuance Cost				19,000
State Filing Fees				3,000
Interest Expense, Debt		24,000	$ 0	48,000	0
Interest Payable		13,000		13,000
Notes and Loans, Noncurrent		1,200,000		$ 1,200,000
Cherokee Loan and Security Agreement [Member] | New Participations [Member]
Line of Credit Facility [Line Items]
Contingent Consideration Additional Restricted Shares Issuable				196,000
Debt Instrument, Periodic Payment, Interest				$ 4,000
Debt Instrument, Interest Rate, Stated Percentage						8.00%
Debt Instrument, Face Amount						$ 511,000
Cherokee Loan and Security Agreement [Member] | Series A Debentures and CAM Bridge Loan [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Periodic Payment, Interest	$ 15,000
Debt Instrument, Interest Rate, Stated Percentage	15.00%
Debt Instrument, Face Amount	$ 689,000
Cherokee Loan and Security Agreement [Member] | Cherokee Financial LLC [Member]
Line of Credit Facility [Line Items]
Contingent Consideration Additional Restricted Shares Issuable				600,000
Stock Issued During Period, Shares, Restricted Stock Award, Gross				1,800,000
Debt Issuance Cost		$ 17,000	$ 0	$ 39,000	$ 0
Cherokee Loan and Security Agreement [Member] | Cantone Research Inc [Member]
Line of Credit Facility [Line Items]
Contingent Consideration Additional Restricted Shares Issuable				0.5
Stock Issued During Period, Shares, Restricted Stock Award, Gross				200,000
Debt Instrument, Fee				As placement agent for the transaction, CRI received a 5% cash fee on the $1.2 million, or $60,000

Line of Credit and Debt - Line

Line of Credit and Debt - Line of Credit with Crestmark Bank ("Crestmark") (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Line of Credit Facility [Line Items]
Interest Expense, Debt			$ 5,000	$ 24,000
Interest Payable	$ 0		0
Debt Instrument, Face Amount	0		0
Crestmark Bank [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	1,500,000		1,500,000
Minimum Loan Balance	500,000		500,000
Interest Expense, Debt	21,000	$ 0	21,000	0
Interest Payable	0		0
Debt Instrument, Face Amount	931,000		931,000
Imperium [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Fee Amount	50,000		50,000
Crestmark Loan And Security Agreeement [Member]
Line of Credit Facility [Line Items]
Legal Fees			3,000
Debt Issuance Cost	6,000	$ 0	8,000	$ 0
Crestmark Loan And Security Agreeement [Member] | Crestmark Bank [Member]
Line of Credit Facility [Line Items]
Monthly Reduction of Inventory Subcap Limit	10,000		10,000
Inventory Subcap Limit	350,000		350,000
Minimum Net Worth Required for Compliance	$ 1,650,000		$ 1,650,000
Line of Credit Facility, Borrowing Capacity, Description			The Maximum Amount is subject to an Advance Formula comprised of: 1) 90% of Eligible Accounts Receivables (excluding, receivables remaining unpaid for more than 90 days from the date of invoice and sales made to entities outside of the United States), and 2) up to 40% of eligible inventory plus up to 10% of Eligible Generic Packaging Components not to exceed the lesser of $500,000 (Inventory Sub-Cap Limit), or 100% of the Eligible Accounts Receivable
Debt Instrument, Restrictive Covenants			If the Company terminates the LSA prior to its 3 year term, an early exit fee is due as follows: 3% of the Maximum Amount (plus any additional amount owed to Crestmark at time of termination) if terminated in year 1, and 2% if terminated in year 2 or anytime thereafter.
Debt Instrument, Fee			the Company will pay Crestmark a Loan Fee of 0.50%, or $7,500, and a Monthly Maintenance Fee of 0.30% of the actual average monthly loan balance from the prior month will be paid to Crestmark
Debt Instrument, Debt Default, Description of Violation or Event of Default			The Extra Rate is the Companys then current interest rate plus 12.75% per annum.
Line of Credit Facility, Interest Rate Description			variable rate based on the Wall Street Journal Prime Rate plus 2% with a floor of 5.25%
Line of Credit Facility, Interest Rate During Period			5.25%
Line of Credit Facility, Interest Rate at Period End	9.35%		9.35%
Payments of Debt Issuance Costs			$ 12,000
Percentage of Net Income, Increase	50.00%		50.00%
Crestmark Loan And Security Agreeement [Member] | Landmark Pegasus Inc [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Fee			a Brokers Fee of 5%, or $75,000
Debt Instrument, Fee Amount	$ 75,000		$ 75,000
Crestmark Loan And Security Agreeement [Member] | Imperium [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Interest Rate During Period			12.00%

Line of Credit and Debt - First

Line of Credit and Debt - First Niagara : Mortgage Consolidation Loan (Details Textual) - USD ($)		1 Months Ended	3 Months Ended		9 Months Ended
		Apr. 28, 2014	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Line of Credit Facility [Line Items]
Long-term Debt, Gross			$ 2,131,000		$ 2,131,000		$ 2,147,000
Interest Expense, Debt					$ 5,000	$ 24,000
Mortgage Payable To First Niagara [Member]
Line of Credit Facility [Line Items]
Mortgage Consolidation Loan Initial Interest Percentage		8.25%			9.25%
Mortgage Consolidation Loan Initial Monthly Payment		$ 13,199	14,115		$ 14,115
Long-term Debt, Gross	[1]		0		$ 0		$ 348,000
Percentage of Renewal Fee					1.00%
Renewal Fee Principal Balance Amount			4,200		$ 4,200
Interest Expense, Debt			$ 0	$ 8,000
[1]	The mortgage through First Niagara Bank was satisfied in full on March 27, 2015 via a refinancing with Cherokee Financial, LLC.

Line of Credit and Debt - Deben

Line of Credit and Debt - Debenture Financing/Bridge Loan (Details Textual) - USD ($)	Feb. 07, 2014	Aug. 31, 2008	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014
Schedule of Capitalization, Long-term Debt [Line Items]
Amortization of Financing Costs					$ 187,000	$ 216,000
Interest Expense, Debt					5,000	24,000
Long-term Debt, Current Maturities, Total			$ 1,006,000		$ 1,006,000				$ 1,837,000
Percentage of Forbearing Principal Amount					2.00%
Debt Instrument, Face Amount			0		$ 0
Period For Amortization Of Financing Costs					6 months
Interest Payable			0		$ 0
Bridge Loan 2013 [Member]
Schedule of Capitalization, Long-term Debt [Line Items]
Debt Instrument, Face Amount							$ 200,000
Debt Conversion, Converted Instrument, Shares Issued							300,000
Bridge Loans 2012 [Member]
Schedule of Capitalization, Long-term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage								15.00%
Debt Instrument, Face Amount								$ 150,000
Warrant [Member]
Schedule of Capitalization, Long-term Debt [Line Items]
Amortization of Financing Costs				$ 3,000		44,000
Deferred Finance Costs, Net			0		0
Debt Related Commitment Fees and Debt Issuance Costs							$ 76,000
Debenture 2013 Extension [Member]
Schedule of Capitalization, Long-term Debt [Line Items]
Unrecognized Expense			0	0
Debenture 2013 [Member]
Schedule of Capitalization, Long-term Debt [Line Items]
Amortization of Financing Costs				21,000		65,000
Deferred Finance Costs, Net			0		0
Debt Related Commitment Fees and Debt Issuance Costs							87,000
Debenture 2013 [Member] | Warrant [Member]
Schedule of Capitalization, Long-term Debt [Line Items]
Amortization of Financing Costs			0		0
Series A Debentures [Member]
Schedule of Capitalization, Long-term Debt [Line Items]
Proceeds from Issuance of Debt		$ 750,000
Amortization of Financing Costs								$ 645,000
Debt Instrument, Interest Rate, Stated Percentage		8.00%
Debt Instrument, Maturity Date		Aug. 1, 2012
Series A Debentures [Member] | Bridge Loan [Member]
Schedule of Capitalization, Long-term Debt [Line Items]
Proceeds from Issuance of Debt	$ 543,000
Long-term Debt, Current Maturities, Total	$ 91,000
Series A Debentures [Member] | Debenture 2013 Extension [Member]
Schedule of Capitalization, Long-term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage								15.00%
Bridge Loan With Cantone Asset Management, LLC [Member]
Schedule of Capitalization, Long-term Debt [Line Items]
Amortization of Financing Costs							$ 634,500
Bridge Loan			523,000		523,000
Bridge Loan With Cantone Asset Management, LLC [Member] | Bridge Loan 2013 [Member]
Schedule of Capitalization, Long-term Debt [Line Items]
Proceeds from Issuance of Debt					20,000
Bridge Loan			$ 200,000		$ 200,000
Bridge Loan With Cantone Asset Management, LLC [Member] | Debenture 2014 Extension [Member]
Schedule of Capitalization, Long-term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage			15.00%		15.00%
New Bridge Loan Agreement 2013 [Member]
Schedule of Capitalization, Long-term Debt [Line Items]
Bridge Loan			$ 543,000		$ 543,000
Debt Instrument, Maturity Date					Aug. 1, 2014
CRI [Member]
Schedule of Capitalization, Long-term Debt [Line Items]
Reimbursed In Legal Fees					$ 1,000
Amortization of Financing Costs					$ 15,000
Restricted Stock Award Issued Price Per Share					$ 0.12
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures					58,575
Percentage of Forbearing Principal Amount					1.00%
Forbearing Principal Amount					$ 7,000
Forbearance [Member]
Schedule of Capitalization, Long-term Debt [Line Items]
Amortization of Financing Costs			0	28,000	0	85,000
Interest Expense, Debt			$ 0	$ 28,000	$ 22,000	$ 85,000

Line of Credit and Debt - Lin26

Line of Credit and Debt - Line of Credit with Imperium Commercial Finance, LLC ("Imperium") (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Line of Credit Facility [Line Items]
Interest Expense, Debt			$ 5,000	$ 24,000
Interest Payable	$ 0		$ 0
Imperium Line Of Credit [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Borrowing Capacity, Description			On March 6, 2014, Imperium amended the Borrowing Base of the Imperium Line of Credit. More specifically, the amount available under the Imperium Line of Credit was capped to the lower of (i) $1,000,000, or (ii) 100% of the eligible outstanding accounts receivable.
Line Of Credit Facility Termination Fee	50,000		$ 50,000
Line Of Credit Facility Costs	435,000		435,000
Debt Issuance Cost	0	$ 34,000	$ 137,000	103,000
Debt Instrument, Convertible, Remaining Discount Amortization Period			3 years
Interest Expense, Debt	0	$ 25,000	$ 39,000	$ 76,000
Long-term Line of Credit	0		0
Amortization of Debt Discount (Premium)			$ 69,000
Maximum Funding Amounts Subject To Discretionary Borrowing Description			EBITDA (Earnings Before Interest, Taxes Depreciation and Amortization) requirements. The Company did not comply with this covenant starting in the First Quarter of 2013. The Company received a waiver from Imperium for the three months ended March 31, 2013 (for which the Company paid a fee of $10,000), but no further formal waivers were issued.
Interest Payable	$ 0		$ 0

Stock Options _ Warrant Grant27

Stock Options / Warrant Grants (Details) - Employee Stock Option [Member] - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Shares, Beginning Balance	1,295,000	3,316,000
Shares, Granted	340,000	80,000
Shares, Exercised	0	0
Shares, Cancelled/expired	(200,000)	(838,000)
Shares, Ending Balance	1,435,000	2,558,000
Exercisable at end of period	1,027,000	2,209,000
Weighted Average Exercise Price, at beginning of period	$ 0.27	$ 0.69
Weighted Average Exercise Price, Granted	0.12	0.12
Weighted Average Exercise Price, Cancelled/expired	0.90	1.07
Weighted Average Exercise Price, at end of period	0.14	0.22
Weighted Average Exercise Price, Exercisable, at end of period	$ 0.15	$ 0.23
Aggregate Intrinsic Value, Outstanding at end of period	$ 16,300	$ 6,150

Stock Options _ Warrant Grant28

Stock Options / Warrant Grants (Details 1)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility		197.00%
Expected term (years)	10 years	7 years 6 months
Risk-free interest rate		0.87%
Dividend yield	0.00%	0.00%
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility	63.00%
Risk-free interest rate	1.92%
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility	64.00%
Risk-free interest rate	2.33%

Stock Options _ Warrant Grant29

Stock Options / Warrant Grants (Details 2) - Warrant [Member] - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Beginning Balance	3,303,000	3,303,000
Shares, Granted	0	0
Shares, Exercised	0	0
Shares, Cancelled/expired	(918,000)	0
Shares, Ending Balance	2,385,000	3,303,000
Exercisable at end of period	2,385,000	3,303,000
Weighted Average Exercise Price, at beginning of period	$ 0.17	$ 0.17
Weighted Average Exercise Price, Cancelled/expired	0.15	0.14
Weighted Average Exercise Price, at end of period	0.17	0.17
Weighted Average Exercise Price, Exercisable, at end of period	$ 0.17	$ 0.17
Aggregate Intrinsic Value outstanding at period	$ 0	$ 0

Stock Options _ Warrant Grant30

Stock Options / Warrant Grants (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			0	0
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	$ 0		$ 0
Debt Issuance Cost	0	$ 25,000	$ 100,000	$ 50,000
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			340,000	80,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	40,000		$ 40,000
Stock Issued	$ 0	$ 0
Employee Stock Option [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			5 months
Employee Stock Option [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			32 months
Fiscal 2001 Non Statutory Stock Option Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			90,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights			The Board member options vest 100% on the 1-year anniversary of the date of the grant and the Waterhouse VG stock option vests over the terms of the Crestmark Line of Credit, or over 3 years.
Fiscal 2001 Non Statutory Stock Option Plan [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			250,000	80,000